Skip to content

Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil

Randomized Clinical Trial of a Brazilian HIV Prevention Intervention for the Severely Mentally Ill

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00881699
Enrollment
460
Registered
2009-04-15
Start date
2006-09-30
Completion date
2011-08-31
Last updated
2012-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection, HIV Infections

Keywords

HIV Information, HIV Prevention, Severe Mental Illness, HIV seronegativity

Brief summary

This study will test the effectiveness of a program aimed at reducing behaviors that increase HIV risk among people with severe mental illnesses.

Detailed description

HIV is a virus that weakens a person's immune system and can cause AIDS. It is most commonly transmitted through unprotected sexual contact. People with a mental illness who are sexually active may be at risk of HIV infection, but most interventions for reducing risk of HIV infection do not target this particular population. This study will test an intervention aimed at reducing behaviors with a high risk of causing HIV infection in sexually active people with a mental illness. Participation in this study will last 15 months. At study entry, participants will complete a baseline interview with a research assistant. This interview will evaluate sexual activity, knowledge of HIV, the participant's psychiatric diagnosis and symptoms, attitude toward condoms, and stigma related to mental illness experienced by the participant. Participants will then be randomly assigned to either an HIV risk reduction group or a general health group. Both of these groups will meet once a week for 8 weeks. Those in the HIV risk reduction group will learn information and take part in activities aimed at reducing behaviors that place people at a high risk of being infected with HIV. Those in the general health group will learn about long-term serious medical conditions, such as diabetes and high blood pressure, that may be common in people with a mental illness. Participants will complete two follow-up visits after their 8-week intervention, one the week after and one 3 months after. Participants will then complete a booster of three weekly group sessions covering the same information from their 8-week intervention. More follow-up visits will occur 1 week and 6 months after participants complete the booster sessions. All follow-up visits will involve an interview similar to the one held at study entry. Additionally, feedback forms will be completed at the first interview at study entry, after the eight group sessions, after the three booster sessions, and at the last interview.

Interventions

BEHAVIORALHIV Prevention Intervention - Project PRISSMA - HIV I have my eye on you

Eight weekly 2-hour HIV risk reduction intervention sessions, with three weekly 2-hour booster sessions completed 6 months after the initial intervention. Specific goals of the intervention are to (1) increase information about HIV risk behaviors and safer sex options; (2) increase identification of personal risk of HIV and enhance the motivation to engage in safer sex behaviors; and (3) enhance skills to achieve safer sex, particularly negotiating safer sex, using condoms, and communicating within a relationship.

Eight weekly 2-hour health promotion intervention sessions with three weekly 2-hour booster sessions completed 6 months after the initial intervention. Specific goals of the intervention are to (1) increase information about health issues specific to psychiatric patients, (2) increase identification of personal health risks and enhance motivation to engage in healthier behaviors, and (3) enhance skills to achieve healthier behaviors.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
New York State Psychiatric Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Being treated as a patient in one of the study psychiatric clinics * Sexually active in the past 3 months

Exclusion criteria

* Primary alcohol or other drug use disorder * Acutely psychotic or actively suicidal at the time of the screening interview * Developmental disability as a primary diagnosis * Unable to speak Portuguese

Design outcomes

Primary

MeasureTime frame
Sexual Risk Behavior Assessment Schedule (SERBAS)Measured at baseline and 3, 6, and 12 months post-intervention

Secondary

MeasureTime frame
Brief HIV Knowledge Questionnaire (Brief HIV-KQ)Measured at baseline and 3, 6, and 12 months post-intervention
Brief Psychiatric Rating Scale (BPRS)Measured at baseline and 3, 6, and 12 months post-intervention
Stigma and Discrimination QuestionnaireMeasured at baseline and 3, 6, and 12 months post-intervention

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026